[Paraproteinemia and Neuropathy: Medical Process to Diagnosis]

Area of Science:

• Neurology
• Hematology
• Immunology

Background:

• Monoclonal proteins (M-proteins) frequently coexist with neuropathy.
• While often incidental, some M-proteins are directly implicated in causing diverse neuropathies.
• The relationship between M-proteins and neuropathy necessitates a thorough diagnostic approach.

Purpose of the Study:

• To outline key considerations for neurologists managing patients with M-protein-associated neuropathies.
• To emphasize the multifaceted investigation required for these complex cases.
• To highlight the importance of monitoring for hematologic malignancy development.

Main Methods:

• Review of clinical presentations of M-protein-induced neuropathies.
• Analysis of neurological, electrophysiological, and pathological findings.
• Evaluation of systemic complications and hematologic malignancy risk.

Main Results:

• M-protein-associated neuropathies present with diverse neurological deficits.
• Investigation requires a combination of clinical, electrical, and pathological assessments.
• A significant risk of progression to hematologic malignancy exists, even with initially benign M-proteins.

Conclusions:

• Neurologists play a crucial role in diagnosing and managing M-protein-associated neuropathies.
• A systematic approach is essential to characterize the M-protein and associated neurological findings.
• Long-term surveillance for hematologic transformation is a critical component of patient care.